(Q39571175)

13 September 2017

Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes (English)

1 reference

13 September 2017

0 references

1 reference

1 reference

I Tkáč

1

1 reference

13 September 2017

L Klimčáková

2

1 reference

13 September 2017

M Javorský

3

1 reference

13 September 2017

M Fabianová

4

1 reference

13 September 2017

Z Schroner

5

1 reference

13 September 2017

H Hermanová

6

1 reference

13 September 2017

E Babjaková

7

1 reference

13 September 2017

R Tkáčová

8

1 reference

13 September 2017

9 September 2012

1 reference

Diabetes, Obesity and Metabolism

13 September 2017

1 reference

13 September 2017

15

1 reference

13 September 2017

2

1 reference

13 September 2017

189-191

1 reference

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

13 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01691.X

Clinical Pharmacokinetics of Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01691.X

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01691.X

Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01691.X

Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01691.X

Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01691.X

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01691.X

Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01691.X

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01691.X

10.1111/J.1463-1326.2012.01691.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference